Neuberger Berman Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,675
| Closed | -$627K | – | 1897 |
|
|
2024
Q1 | $627K | Sell |
10,675
-1,783
| -14% | -$105K | ﹤0.01% | 1426 |
|
|
2023
Q4 | $746K | Buy |
+12,458
| New | +$746K | ﹤0.01% | 1364 |
|
|
2023
Q3 | – | Sell |
-4,201
| Closed | -$383K | – | 1810 |
|
|
2023
Q2 | $383K | Sell |
4,201
-36,547
| -90% | -$3.33M | ﹤0.01% | 1515 |
|
|
2023
Q1 | $2.69M | Sell |
40,748
-14,750
| -27% | -$973K | ﹤0.01% | 1008 |
|
|
2022
Q4 | $2.87M | Buy |
55,498
+11,164
| +25% | +$577K | ﹤0.01% | 988 |
|
|
2022
Q3 | $3.03M | Buy |
44,334
+290
| +0.7% | +$19.8K | ﹤0.01% | 995 |
|
|
2022
Q2 | $1.99M | Buy |
44,044
+2,138
| +5% | +$96.7K | ﹤0.01% | 1110 |
|
|
2022
Q1 | $2.13M | Sell |
41,906
-59,217
| -59% | -$3.01M | ﹤0.01% | 1161 |
|
|
2021
Q4 | $4.68M | Buy |
101,123
+36,927
| +58% | +$1.71M | ﹤0.01% | 994 |
|
|
2021
Q3 | $2.12M | Buy |
+64,196
| New | +$2.12M | ﹤0.01% | 1160 |
|